Drawing for SENSIUMVITALS

USPTO serial 86069105

SENSIUMVITALS

Reviewed by CopyMark Law Group

Reg. 4906912Status 702Registered
Filing date
Status date
Registration date
Mar 1, 2016
Examiner
COLEMAN, NICHOLAS A
Law office
TMO LAW OFFICE 115

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SENSIUMVITALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mainak H. Mehta

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B. Street, Suite 2200San Diego, CA 92101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; computer software for controlling and managing patient medical information; computer hardware for receiving and processing apparatus for data, sound, images, information and signals, namely, computer hardware and specialized adhesive bandages, plasters and patches comprised of small sensors, thin batteries and antennas sold as unit; wireless communication devices, namely, computers, antennas, hubs, routers, personal digital assistants (PDAs), smartphones, mobile telephones, modems, communications hubs; radio converters; electronic communication devices and apparatus; visual display apparatus, namely, LCD screens, plasma display panels for medical images, electronic image display screens, electronic display interfaces, flat panel display screens, display monitors, mobile data units and terminals; computer units and terminals; electronic display screens, namely, liquid crystal displays, light emitting diode displays, plasma displays, and electrophoretic and flat panel displays; structural parts and fittings for all the aforesaid goods; computer software for wireless communication and provision, acquisition, management, monitoring, analysis, storage, recording, processing, communication, transmission, provision, collection, presentation and broadcasting of data, vital signs, medical, physiological and bio-chemical information; electronic apparatus, namely, stand-alone displays for medical imagesACTIVE
010Medical diagnostic and sensing devices and apparatus, namely, sensors that can be attached to the body with a sticking plaster, bandage or adhesive patch to enable non-intrusive, continuous monitoring, broadcasting, communication and analysis of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs; medical devices, apparatus and instruments incorporating wireless communication devices and sensors, biosensors, chemical sensors and optical sensors, namely, wireless communication sensors, biosensors, chemical sensors, and optical sensors that utilize body wearable bandages, plasters and adhesive patches for use in the remote monitoring of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs and physiological information; medical products, namely, body wearable and implantable sensors and antennas for monitoring, recording, broadcasting and transmitting vital signs and other medical and physiological information, and body wearable and implantable sensors for sensing, monitoring, recording and transmitting of analog, radio frequency (RF), and global positioning satellite (GPS) signals and information concerning physiological parameters of the body, comprised of small sensors, thin batteries, and antennas; medical devices, namely, adhesive bandages, plasters and patches comprised of small sensors, thin batteries and antennas for use in the remote monitoring of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs and physiological information; electrical and electronic biosensors, chemical sensors, electrical and optical sensors for use in wireless patient body monitoring; medical devices, namely, body wearable and/or implantable sensors that interface with display and notification devices, pagers, tablet computers, mobile telephones, personal digital assistants (PDAs) and computers for use in continuous vital sign, bio-chemical and physiological monitoring and receiving and processing apparatus therefor, namely, base stations and mobile computing and operating platforms consisting of data transceivers, wireless networks and gateways for collection and management of physiological and medical data; computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual, namely, liquid crystal display (LCD) screens, plasma display panels, electronic image display screens, electronic display interfaces, flat panel display screens; computer hardware and software, specifically adapted for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying dataACTIVE
035Collection and management of data in the nature of data compilation and database management; data processing services in the field of healthcare; business consultancy services relating to the data processing in the field of medical, physiological, and bio-chemical health, information and data; computer file management, namely, management and compilation of computerized databasesACTIVE
039Consultancy services relative to the physical storage of electronically-stored medical, physiological and bio-chemical information and data; physical storage of electronically-stored data or documents, namely, medical, physiological and bio-chemical information and dataACTIVE
042Design and development of sensing, monitoring, recording and transmission of signals and provision of information related thereto and design and development of data receiving and processing apparatus, wireless communication devices, biosensors, chemical sensors, electrical and optical sensors; research and consultancy services relating to all the aforesaid; technical support services, namely, troubleshooting of computer software problems, diagnosing problems with medical equipment and remote administration and management of in-house and hosted datacentre devices, databases and software applications; scientific analysis of data derived from sensors, biosensors, chemical and optical sensors and information, advisory information and consultancy services relating to scientific analysis of data derived from sensors, biosensors, chemical and optical sensors; biomedical research services, namely, collection, preparation, composition, acquisition, and provision of medical, physiological, and bio-chemical information and data for scientific research purposes; consultancy services relating to the collection, preparation, composition, acquisition, analysis and management of medical, physiological, and bio-chemical information and data for scientific research purposes; electronic data storage, namely, medical, physiological and bio-chemical information and data; computer services, namely, remote management of compilation of computerized databases of others; computer software consultancy, namely consultancy relative to the electronic storage of medical, physiological, and bio-chemical information and dataACTIVE
044Collection, preparation, composition, acquisition, and provision of medical, physiological, and bio-chemical information and data for treatment and diagnostic purposes; consultancy services relating to the collection, preparation, composition, storage, processing, acquisition, analysis, and management of medical, physiological, and bio-chemical information and data for treatment and diagnostic purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 2, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 13, 2022NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 13, 2022C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 30, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 26, 2022E815TEAS SECTION 8 & 15 RECEIVED
Mar 1, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 1, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 26, 2016DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jan 16, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 30, 2015IUCNNOTICE OF ALLOWANCE CANCELLED
Nov 30, 2015D1BRTEAS DELETE 1(B) BASIS RECEIVED
Jun 2, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 7, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 3, 2015ALIEASSIGNED TO LIE
Feb 12, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2015XAECEXAMINER'S AMENDMENT ENTERED
Feb 12, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 12, 2015GNEAEXAMINERS AMENDMENT E-MAILED
Feb 12, 2015CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 9, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2014ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 21, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 21, 2014GNSLLETTER OF SUSPENSION E-MAILED
Jul 21, 2014CNSLSUSPENSION LETTER WRITTEN
Jun 28, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 9, 2014ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 31, 2013GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 31, 2013GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 31, 2013CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 30, 2013DOCKASSIGNED TO EXAMINER
Sep 27, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED
Sep 26, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2013NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance